Undetectable: How Viral Load Monitoring Can Improve HIV Treatment in Developing Countries
Putting HIV and HCV to the Test: A Product Guide for Point-of-Care CD4 and Laboratory-Based and Point-of-Care Virological HIV and HCV Tests.
Today, eight million people in developing countries have access to HIV therapy and while many more need to be reached with life-saving medicines, this is important progress. However, the monitoring that goes hand in hand with HIV treatment is still lagging behind in developing countries.
• helps identify people who may be having trouble sticking to their treatment and need support
• helps identify those who are failing their treatment because the virus has become resistant to the drugs they are taking and who need to be switched to another treatment regimen
• Describing the importance of viral load monitoring
• Assessing the current state of play in terms of implementation of viral load testing in the developing world
• Exploring how to overcome technical barriers by looking at the research and development (R&D) pipeline and defining the ideal specifications of a viral load test for resourcelimited settings
• Identifying strategies to overcome market barriers in order to make viral load monitoring more affordable.